We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
4151
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.53K ﹤0.01%
327
+295
+922% +$4.43K
KOPN icon
4152
Kopin
KOPN
$930M
$4.52K ﹤0.01%
6,662
PFSW
4153
DELISTED
PFSweb, Inc.
PFSW
$4.46K ﹤0.01%
1,763
AQST icon
4154
Aquestive Therapeutics
AQST
$531M
$4.45K ﹤0.01%
1,399
NXTC icon
4155
NextCure
NXTC
$37.4M
$4.35K ﹤0.01%
12
+11
+1,100% +$3.58K
SER icon
4156
Serina Therapeutics
SER
$42.3M
$4.34K ﹤0.01%
63
+29
+85% +$2.75K
TESS
4157
DELISTED
Tessco Technologies Inc
TESS
$4.34K ﹤0.01%
302
+5
+2% +$78
MLNT
4158
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$4.29K ﹤0.01%
1,125
YXI icon
4159
ProShares Short FTSE China 50 of PROSHARES TRUST
YXI
$4.72M
$4.22K ﹤0.01%
105
-1,225
-92% -$48.5K
METC icon
4160
Ramaco Resources Class A
METC
$692M
$4.09K ﹤0.01%
1,133
+45
+4% +$194
TBHC
4161
DELISTED
The Brand House Collective
TBHC
$4.06K ﹤0.01%
2,635
SHSP
4162
DELISTED
SharpSpring, Inc.
SHSP
$4.05K ﹤0.01%
418
+396
+1,800% +$4.37K
MEC icon
4163
Mayville Engineering Co
MEC
$596M
$4.05K ﹤0.01%
307
+291
+1,819% +$3.89K
IBRX icon
4164
ImmunityBio
IBRX
$8.2B
$4.03K ﹤0.01%
3,306
NTGN
4165
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$4.03K ﹤0.01%
2,344
+42
+2% +$128
CLUB
4166
DELISTED
Town Sports International Holdings, Inc.
CLUB
$3.99K ﹤0.01%
2,433
VALU icon
4167
Value Line
VALU
$360M
$3.98K ﹤0.01%
175
+52
+42% +$1.32K
SBBP
4168
DELISTED
Strongbridge Biopharma plc.
SBBP
$3.97K ﹤0.01%
+1,660
New +$4.46K
AXIA
4169
DELISTED
AXIA Energia
AXIA
$3.95K ﹤0.01%
520
CWBR
4170
DELISTED
CohBar, Inc. Common Stock
CWBR
$3.89K ﹤0.01%
100
VIVS
4171
VivoSim Labs
VIVS
$1.16M
$3.87K ﹤0.01%
62
MARK
4172
DELISTED
Remark Holdings, Inc.
MARK
$3.86K ﹤0.01%
369
DTIL icon
4173
Precision BioSciences
DTIL
$205M
$3.75K ﹤0.01%
15
+14
+1,400% +$4.56K
RNGR icon
4174
Ranger Energy Services
RNGR
$405M
$3.56K ﹤0.01%
552
NCSM icon
4175
NCS Multistage Holdings
NCSM
$134M
$3.54K ﹤0.01%
88

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.